ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Oncocyte Corporation

Oncocyte Corporation (OCX)

2.21
-0.02
(-0.90%)
Closed January 10 3:00PM
2.21
0.00
(0.00%)
After Hours: 5:44PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
2.21
Bid
2.10
Ask
2.48
Volume
8,211
2.13 Day's Range 2.32
1.97 52 Week Range 3.5687
Market Cap
Previous Close
2.23
Open
2.22
Last Trade
60
@
2.21
Last Trade Time
Financial Volume
US$ 18,344
VWAP
2.2341
Average Volume (3m)
89,510
Shares Outstanding
16,835,247
Dividend Yield
-
PE Ratio
-1.30
Earnings Per Share (EPS)
-1.71
Revenue
7.27M
Net Profit
-28.72M

About Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers.... OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Headquarters
Irvine, California, USA
Founded
-
Oncocyte Corporation is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker OCX. The last closing price for Oncocyte was US$2.23. Over the last year, Oncocyte shares have traded in a share price range of US$ 1.97 to US$ 3.5687.

Oncocyte currently has 16,835,247 shares outstanding. The market capitalization of Oncocyte is US$37.54 million. Oncocyte has a price to earnings ratio (PE ratio) of -1.30.

OCX Latest News

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicineWill provide key regulatory and reimbursement supportWill assist business...

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific...

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief...

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its...

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms 

Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to...

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phaseFDA...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.16-6.751054852322.372.44992.18231702.28427784CS
4-0.27-10.88709677422.482.691.97727182.26787838CS
12-0.91-29.16666666673.123.21.97895102.52336473CS
26-0.76-25.58922558922.973.47991.97537992.68878695CS
52-1.1-33.23262839883.313.56871.97483672.73082397CS
156-38.79-94.60975609764145.21.9723331914.80632715CS
260-67.59-96.833810888369.81251.9730749843.36029311CS

OCX - Frequently Asked Questions (FAQ)

What is the current Oncocyte share price?
The current share price of Oncocyte is US$ 2.21
How many Oncocyte shares are in issue?
Oncocyte has 16,835,247 shares in issue
What is the market cap of Oncocyte?
The market capitalisation of Oncocyte is USD 37.54M
What is the 1 year trading range for Oncocyte share price?
Oncocyte has traded in the range of US$ 1.97 to US$ 3.5687 during the past year
What is the PE ratio of Oncocyte?
The price to earnings ratio of Oncocyte is -1.3
What is the cash to sales ratio of Oncocyte?
The cash to sales ratio of Oncocyte is 5.12
What is the reporting currency for Oncocyte?
Oncocyte reports financial results in USD
What is the latest annual turnover for Oncocyte?
The latest annual turnover of Oncocyte is USD 7.27M
What is the latest annual profit for Oncocyte?
The latest annual profit of Oncocyte is USD -28.72M
What is the registered address of Oncocyte?
The registered address for Oncocyte is 15 CUSHING, IRVINE, CALIFORNIA, 92618
What is the Oncocyte website address?
The website address for Oncocyte is www.oncocyte.com
Which industry sector does Oncocyte operate in?
Oncocyte operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.82M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.71M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.51M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.6M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.8M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.84M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.36M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
203.16M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
174.94M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
174.87M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.42M

Discussion

View Full Feed
RickNagra RickNagra 3 minutes ago
https://youtu.be/lQgdbs0UIF4
FNMA
Moonboy1 Moonboy1 4 minutes ago
Awesome after hrs close tonight. Heading back up next week?
TNXP
surfkast surfkast 5 minutes ago
Pathological hatred for scammers. George wants to remind his minions that he went from 14 ponies to over 100 thanks to them. Not to mention needing at least $4 million a year to run his stable. He again was short at least $3 million last year! 😭
WNFT
ergo sum ergo sum 5 minutes ago
Why do you have to always bring personal attack?

That is the weakest way to make a point.
williamssc williamssc 6 minutes ago
After several meetings EMA requested we apply for full approval. Followed by EMA excepted our application. Seems the only thing defective is the shorts plan.
AVXL
stockinspector stockinspector 6 minutes ago
I for one think good times are getting close!
The incoherent bashers know that as well, right kz?
In fact some dedicate all their free forum time trying to tie
bad with good knowing that they are spreading fairy tales!
WDLF
delerious1 delerious1 7 minutes ago
I missed most of the day because I was out but from what I've seen, this was good news , taken well by "the market".
From a Fundamental point of view NR's like this will boost the shareprice by solidifying the Base, then once we start getting actual numbers from the Metallurgy Laboratory and
NBRI
ergo sum ergo sum 7 minutes ago
The 2020 Honda CR-V had a starting price of around $26,325, depending on the trim and options. The price range was up to $37,225.

2024 $30,895–$37,555
arizona1 arizona1 7 minutes ago
All Red Taker states!

The Long, Tainted Ascent of JD Vance's Likely Replacement--and What It Says About Ohio

Among its many qualities, who knew that the city of Miami was an overwhelming leader in the occurrence of Medicare fraud?

Not me, until I read M
DrivenByPain DrivenByPain 8 minutes ago
L2s From Today ! 240+ Million On The Bid Side 🤑

https://investorshub.advfn.com/uimage/uploads/2025/1/10/oehufL2s$$.png
SGDH
StayHumble StayHumble 8 minutes ago
Great!!💹8M+ $HIRU XPERT💹BUYS💹💹💹https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades
HIRU
Clark6290 Clark6290 8 minutes ago
Key word is COULD. Still nothing but a gamble my Amigo.
FNMA
Whalatane Whalatane 9 minutes ago
So the risk here is that they raise cash or do a reverse split before the PDUFA date .
JMO
Kiwi
UNCY
teamreal teamreal 10 minutes ago
Up a buck after closing, news drop! 
RUM
fung_derf fung_derf 10 minutes ago
I don't care what complexes you possess. It's in your head.
jimr1717 jimr1717 10 minutes ago
Tesla auto pilot Saves the Life of a Pedestrian.

15 Oct 2024,


https://www.autoevolution.com/news/tesla-veers-to-avoid-pedestrian-who-fell-right-in-front-of-it-crashes-into-oncoming-car-241294.html
TSLA
TurboHaven10 TurboHaven10 11 minutes ago
Pretty sure uplist to nasdaq is impossible until a considerably higher share price
AZRH
facts_matter14 facts_matter14 12 minutes ago
Recycling from 2018, 2019, 2020, 2021, 2022, 2023, and 2024.

This buyout talk is beyond ridiculous. Maxine can’t get even get a toxic loan.

Can it b will now lecture you on why a buyout would be bad, as if it would ever happen anyways.

Down 99%. Ouch.
SRMX
georgejjl georgejjl 12 minutes ago
From Dr. Kun Jin PHD and Dr. Guoqiao Wang PHD

Improve Statistical Efficacy Inference: Global Reduction Rate in Disease Progression

https://pubmed.ncbi.nlm.nih.gov/39782388/

Good luck and GOD bless,
AVXL
fung_derf fung_derf 12 minutes ago
No I'm not. I'm looking at the cost of a car and house. It's very real indeed. I posted you facts from Volvo's website.
You guys need to believe at any cost I guess.
Sorry man, for someone who doesn't think about Trump

https://investorshub.advfn.com/boards/msgsearchbymem
Whalatane Whalatane 13 minutes ago
Well their existing options are probably worthless ....so if you want your key guys to stay ....offer them a deal they can't refuse .
Just my jaded opinion .
For the optimists here ....they issued them a bunch of free options so they can really cash in on the Buy Out some here expect
AMRN
Explosivo Explosivo 14 minutes ago
You mean like nomodo? Who is a mod here?
HMBL
bigworld bigworld 14 minutes ago
gfp: Rising oil prices are another headwind to further gains in the equity markets.
here2help here2help 14 minutes ago
The company answered my post on Twitter today,

Me:
Please provide links and videos ASAP, very exciting news. Shareholders need to see this! So they can share in the excitement too.

International Endeavors Corp:
@IDVVcorp

A video interview fo
IDVV